Browsing by Author Saglio, Giuseppe

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)
1-Feb-2004Aberrant promoter methylation of multiple genes throughout the clinico-pathologic spectrum of B-cell neoplasiaRossi, Davide; Capello, Daniela; Gloghini, Annunziata; Franceschetti, Silvia; Paulli, Marco; Bhatia, Kishor; Saglio, Giuseppe; Vitolo, Umberto; Pileri, Stefano A.; Esteller, Manel; Carbone, Antonino; Gaidano, Gianluca
10-Jul-2016Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients TrialCortes, Jorge E.; Saglio, Giuseppe; Kantarjian, Hagop M.; Baccarani, Michele; Mayer, Jiří; Boqué Genovard, Concepción; Shah, Neil P.; Chuah, Charles; Casanova, Luis; Bradley-Garelik, Brigid; Manos, George; Hochhaus, Andreas
5-Feb-2014Safety and efficacy of switching to nilotinib 400 mg twice daily for patients with chronic myeloid leukemia in chronic phase with suboptimal response or failure on frontline imatinib or nilotinib 300 mg twice daily.Hughes, Timothy P.; Hochhaus, Andreas; Kantarjian, Hagop M.; Cervantes Requena, F.; Guilhot, François; Niederwieser, Dietger; le Coutre, Philipp D.; Rosti, Gianantonio; Ossenkoppele, Gert J.; Lobo, Clarisse; Shibayama, Hirohiko; Fan, Xiaolin; Menssen, Hans D.; Kemp, Charisse; Larson, Richard A.; Saglio, Giuseppe